Literature DB >> 24510597

Schistosomiasis.

Matthew S Tucker1, Laksiri B Karunaratne1, Fred A Lewis1, Tori C Freitas2, Yung-San Liang1.   

Abstract

Schistosomiasis is the second most important parasitic disease in the world in terms of public health impact. Globally, it is estimated that the disease affects over 200 million people and is responsible for 200,000 deaths each year. The three major schistosomes infecting humans are Schistosoma mansoni, S. japonicum, and S. haematobium. Much immunological research has focused on schistosomiasis because of the pathological effects of the disease, which include liver fibrosis and bladder dysfunction. This unit covers a wide range of aspects with respect to maintaining the life cycles of these parasites, including preparation of schistosome egg antigen, maintenance of intermediate snail hosts, infection of the definitive and intermediate hosts, and others. The unit primarily focuses on S. mansoni, but also includes coverage of S. japonicum and S. haematobium life cycles.
Copyright © 2013 John Wiley & Sons, Inc.

Entities:  

Keywords:  haematobium; japonicum; mansoni; schistosomiasis; snail

Mesh:

Year:  2013        PMID: 24510597     DOI: 10.1002/0471142735.im1901s103

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  46 in total

1.  Sm-p80-based schistosomiasis vaccine: double-blind preclinical trial in baboons demonstrates comprehensive prophylactic and parasite transmission-blocking efficacy.

Authors:  Weidong Zhang; Adebayo J Molehin; Juan U Rojo; Justin Sudduth; Pramodh K Ganapathy; Eunjee Kim; Arif J Siddiqui; Jasmin Freeborn; Souad R Sennoune; Jordan May; Samra Lazarus; Catherine Nguyen; Whitni K Redman; Gul Ahmad; Workineh Torben; Souvik Karmakar; Loc Le; Kameswara R Kottapalli; Pratibha Kottapalli; Roman F Wolf; James F Papin; David Carey; Sean A Gray; Jenn D Bergthold; Raymond T Damian; Bryan T Mayer; Florian Marks; Steven G Reed; Darrick Carter; Afzal A Siddiqui
Journal:  Ann N Y Acad Sci       Date:  2018-08       Impact factor: 5.691

2.  Negative Association of Interleukin-33 Plasma Levels and Schistosomiasis Infection in a Site of Polyparasitism in Rural Cameroon.

Authors:  Severin Donald Kamdem; Francis Konhawa; Erve Martial Kuemkon; Leonel Meyo Kamguia; Gladys K Tchanana; Frungwa Nche; Alim Oumarou; Mamadou Hamza; Yasmine Ouratou; Mariette Nzoku Tcheutchoua; René Ghislain Essomba; Marie Paule Ngogang; Michel Kengne; Palmer Masumbe Netongo; Bienvenu Etogo Ondigui; Marie Claire Okomo Assoumou; Frank Brombacher; Justin Komguep Nono
Journal:  Front Immunol       Date:  2019-12-03       Impact factor: 7.561

3.  CD14 influences host immune responses and alternative activation of macrophages during Schistosoma mansoni infection.

Authors:  Smanla Tundup; Leena Srivastava; Tamas Nagy; Donald Harn
Journal:  Infect Immun       Date:  2014-05-27       Impact factor: 3.441

4.  Schistosoma haematobium cercarial infection alters subsequent systemic immune responses to eggs but has minimal impact on immune responses to egg injection of the bladder.

Authors:  Le Loc; Evaristus C Mbanefo; George Khludenev; Olivia Lamanna; Nirad Banskota; Michael H Hsieh
Journal:  Parasite Immunol       Date:  2018-12-03       Impact factor: 2.280

5.  Characterization of Lead Compounds Targeting the Selenoprotein Thioredoxin Glutathione Reductase for Treatment of Schistosomiasis.

Authors:  Haining Lyu; Pavel A Petukhov; Paul R Banta; Ajit Jadhav; Wendy A Lea; Qing Cheng; Elias S J Arnér; Anton Simeonov; Gregory R J Thatcher; Francesco Angelucci; David L Williams
Journal:  ACS Infect Dis       Date:  2020-01-24       Impact factor: 5.084

6.  Tim-3 induces Th2-biased immunity and alternative macrophage activation during Schistosoma japonicum infection.

Authors:  Nan Hou; Xianyu Piao; Shuai Liu; Chuang Wu; Qijun Chen
Journal:  Infect Immun       Date:  2015-05-18       Impact factor: 3.441

7.  The impact of schistosomes and schistosomiasis on murine blood coagulation and fibrinolysis as determined by thromboelastography (TEG).

Authors:  Akram A Da'dara; Armelle M de Laforcade; Patrick J Skelly
Journal:  J Thromb Thrombolysis       Date:  2016-05       Impact factor: 2.300

8.  Identification of Antigenic Glycans from Schistosoma mansoni by Using a Shotgun Egg Glycan Microarray.

Authors:  Megan L Mickum; Nina Salinger Prasanphanich; Xuezheng Song; Nelum Dorabawila; Msano Mandalasi; Yi Lasanajak; Anthony Luyai; W Evan Secor; Patricia P Wilkins; Irma Van Die; David F Smith; A Kwame Nyame; Richard D Cummings; Carlos A Rivera-Marrero
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

9.  Cross-species prophylactic efficacy of Sm-p80-based vaccine and intracellular localization of Sm-p80/Sm-p80 ortholog proteins during development in Schistosoma mansoni, Schistosoma japonicum, and Schistosoma haematobium.

Authors:  Adebayo J Molehin; Souad R Sennoune; Weidong Zhang; Juan U Rojo; Arif J Siddiqui; Karlie A Herrera; Laura Johnson; Justin Sudduth; Jordan May; Afzal A Siddiqui
Journal:  Parasitol Res       Date:  2017-10-12       Impact factor: 2.289

10.  Mitochondria as a Potential Target for the Development of Prophylactic and Therapeutic Drugs against Schistosoma mansoni Infection.

Authors:  Keith Kiplangat Talaam; Daniel Ken Inaoka; Takeshi Hatta; Daigo Tsubokawa; Naotoshi Tsuji; Minoru Wada; Hiroyuki Saimoto; Kiyoshi Kita; Shinjiro Hamano
Journal:  Antimicrob Agents Chemother       Date:  2021-08-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.